Citius Oncology CTOR
NASDAQ CTOR
$0.67 -0.03 (-4.80%)
As of: Oct 22, 2026 · 11:09 AM EDT

Citius Oncology (CTOR) Cash from Operations (2023 - 2026)

Updated

Citius Oncology (CTOR) reported Cash from Operations of -$2.71 million for fiscal Q3 2026 (quarter ended Jun 30, 2026).

Analysis

Citius Oncology (CTOR) Cash from Operations (2023 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Citius Oncology's Cash from Operations came in at -$14.26 million; for FY2025 (ended Sep 30, 2025), it was -$5.49 million.

  • By fiscal year, Cash from Operations came in at $126,353 in FY2024, -$601,304 in FY2023 and -$47,968 in FY2022.
  • The fiscal Q3 2026 figure ranks as the highest quarterly Cash from Operations since fiscal Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. (Qtr)
1 Eli Lilly 1,172.05 Bn 1,140.63 Bn 19.71 Bn 10.69 Bn
2 Johnson & Johnson 636.25 Bn 554.77 Bn 17.26 Bn 8.62 Bn
3 AbbVie 503.38 Bn 476.49 Bn 12.70 Bn 3.44 Bn
4 Merck 377.92 Bn 332.30 Bn 12.21 Bn 5.37 Bn
5 Novartis Ag 304.19 Bn 268.18 Bn 11.24 Bn 5.88 Bn
6 Astrazeneca 267.24 Bn 240.93 Bn 12.86 Bn 2.87 Bn
7 Amgen 242.06 Bn 197.46 Bn 7.24 Bn 4.00 Bn
8 Gilead Sciences 193.78 Bn 167.97 Bn 6.22 Bn 3.57 Bn
9 Pfizer 172.54 Bn 119.18 Bn 10.94 Bn 835.00 Mn
10 Citius Oncology 71.62 Mn 41.20 Mn 1.00 Mn -2.71 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2.71 Mn
Mar 31, 2026 -3.83 Mn
Dec 31, 2025 -7.35 Mn
Jun 30, 2024 -366,106.00
Mar 31, 2024 -191,690.00
Jun 30, 2023 -100,256.00
Mar 31, 2023 -168,799.00
API Access

Citius Oncology Cash from Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-operations&ticker=CTOR&period=max&api_key=YOUR_API_KEY